ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2168 • 2013 ACR/ARHP Annual Meeting

    Temporomandibular Joint Involvement and Quality Of Life In Juvenile Idiopathic Arthritis

    Paula Frid1,2, Ellen Nordal3,4, Francesca Bovis5, Denise Marafon5, Donato De Angelis5, Sheila Oliveira5, Fabrizia Corona5, Gabrieli Simonini5, Joyce Davidson5, Helen Foster5, Rik Joos5, Ivan Foeldvari5, Michel Steenks5, Pekka Lahdenne5, Pavla Dolezalova5, Elena Palmisani5, Alberto Martini5, Angela Pistorio5 and Nicolino Ruperto5, 1Department of Otorhinolaryngology, Division of Oral and Maxillofacial Surgery, University Hospital North Norway, Tromso, Norway, 2Public Dental Service Competence Centre of Northen Norway, Tromso, Norway, 3Department of Clinical Medicine, University of Tromsø, Tromsø, Norway, 4Department of Pediatrics, University Hospital of North Norway, Tromsø, Norway, 5Istituto Giannina Gaslini, Pediatria II, Reumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO) Coordinating Center, Genoa, Italy, Genoa, Italy

    Background/Purpose: Temporomandibular joint (TMJ) arthritis in childhood is seen in a substantial percentage of children with Juvenile idiopathic arthritis (JIA) and may lead to reduced mouth…
  • Abstract Number: 2169 • 2013 ACR/ARHP Annual Meeting

    Short Term Efficacy Of Biologic Agents In Patients With Systemic Juvenile Idiopathic Arthritis: Network Meta-Analysis Of Randomized Trials

    Simon Tarp1, Gil Amarilyo2, Ivan Foeldvari3, Neta Cohen4, Tracy D. Pope5, Jennifer M.P. Woo6, Robin Christensen1 and Daniel Furst5, 1Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, 2Dana-Dwek Children's hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3Department of Pediatric Rheumatology, Hamburger Zentrum für Kinder und Jugendrheumatologie, Hamburg, Germany, 4Dana-Duek Children's hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 5David Geffen School of Medicine, University of California, Los Angeles, CA, 6Pediatric Rheumatology, Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA

    Background/Purpose: Systemic juvenile idiopathic arthritis (SJIA) is a severe subtype of JIA, which includes systemic features such as fever, rash, elevated inflammatory markers along with…
  • Abstract Number: 2149 • 2013 ACR/ARHP Annual Meeting

    Safety Of Lower-Dose Diclofenac Submicron Particle Capsules Dosed Up To 12 Weeks In Patients With Osteoarthritis

    Clarence Young1 and Marc C. Hochberg2, 1Iroko Pharmaceuticals, Philadelphia, PA, 2Medicine, University of Maryland School of Medicine, Baltimore, MD

    Background/Purpose: Osteoarthritis (OA) is the most common cause of disability in the US and is frequently managed with non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs, including diclofenac,…
  • Abstract Number: 2129 • 2013 ACR/ARHP Annual Meeting

    The Diagnostic Utility Of Anterior Knee Pain and Pain With Activities In Identifying Knees With MRI-Detected Structural Damage In The Patellofemoral Joint: The Multicenter Osteoarthritis Study

    Joshua J. Stefanik1, Tuhina Neogi2, Jingbo Niu2, Neil A. Segal3, Cora E. Lewis4, Michael C. Nevitt5, Frank Roemer6, Ali Guermazi7 and David T. Felson8, 1Clinical Epidemiology, Boston University, Boston, MA, 2Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 3Orthopaedics and Rehabilitation, University of Iowa, Iowa City, IA, 4Preventive Medicine, University of Alabama, Birmingham, Birmingham, AL, 5Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 6Klinikum Augsburg, Augsburg, Germany, 7Boston University, Boston, MA, 8Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: It is widely thought that patellofemoral joint (PFJ) pathology, a source of symptoms in knee osteoarthritis (OA), can be identified using patient history and…
  • Abstract Number: 2130 • 2013 ACR/ARHP Annual Meeting

    Factors Associated With Two-Year Pain Experience Outcome In Knee Osteoarthritis

    Jamie E. Rayahin1, Joan S. Chmiel2, Orit Almagor2, Laura Belisle2, Alison H. Chang3, Kirsten Moisio2, Karen W. Hayes2, Yunhui Zhang2 and Leena Sharma2, 1University of Illinois, Chicago, Chicago, IL, 2Northwestern University, Chicago, IL, 3Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, IL

    Background/Purpose:   Few strategies to improve pain outcome in knee OA exist, in part because methods to evaluate this outcome are not established.  ICOAP development…
  • Abstract Number: 2131 • 2013 ACR/ARHP Annual Meeting

    Osteoarthritis Pain: Variability and Clinical Correlations

    Thomas J. Schnitzer1, Renita Yeasted2, Leijan Huang3, Jennifer Duffecy4, Mark Begale4 and A. Vania Apkarian3, 1PM&R and Int Med, Northwestern University, Chicago, IL, 2PM&R, Northwestern University, Chicago, IL, 3Physiology, Northwestern University, Chicago, IL, 4Preventive Medicine, Northwestern University, Chicago, IL

    Background/Purpose: Although osteoarthritis (OA) is an intensely studied model of chronic pain, little is known about the temporal dynamics of OA pain intensity and how…
  • Abstract Number: 2132 • 2013 ACR/ARHP Annual Meeting

    Short-Run Transitions In Pain States: Reflections Of Multiple Outcome Clinical Measures of Inadequate Pain Relief among Patients With Knee Osteoarthiritis

    Stephanie Taylor1, Christopher Black2, Paul M. Peloso3, Philip G. Conaghan4, Leah Stokes2, Mart A.F.J. van de Laar5, François Rannou6, Nigel K. Arden7 and Panagiotis Mavros2, 1Global Health Outcomes, Merck & Co., Inc., Whitehouse Station, NJ, 2Global Health Outcomes, Merck, Whitehouse Station, NJ, 3Clinical Research, Merck Sharp & Dohme Corp., Rahway, NJ, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 5Rheumatology, University of Twente & Medisch Spectrum Twente, Enschede, Netherlands, 6Physical Medicine and Rehabilitation Service, Paris-Descartes University, Cochin Hospital, Paris, France, 7NDORMS; MRC Lifecourse Epidemiology Unit, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom

    Background/Purpose: Despite the importance of pain management in osteoarthritis (OA), there has been limited evidence confirming the adequacy of measuring pain relief in clinical practice setting. The objective of…
  • Abstract Number: 2133 • 2013 ACR/ARHP Annual Meeting

    Neuropathic Pain After Primary Total Hip and Knee Arthroplasty

    Anne Lubbeke1, Gabor J. Puskas1, Domizio Suva1, Sylvette Bas2, Cem Gabay2, Axel Finckh3 and Pierre Hoffmeyer1, 1Orthopaedic Surgery, Geneva University Hospitals, Geneva, Switzerland, 2Rheumatology, Geneva University Hospitals, Geneva, Switzerland, 3Rheumatology, Geneva University Hospital, Geneva, Switzerland

    Background/Purpose: A sizeable number of patients continue to suffer from pain after total joint arthroplasty (TJA). The reason for this is not well established in…
  • Abstract Number: 2134 • 2013 ACR/ARHP Annual Meeting

    Responsiveness and Predictive Ability Of The Knee Society Scale (KSS) Score

    Jasvinder A. Singh1,2, Cathy Schleck3, W. Scott Harmsen4 and David Lewallen5, 1Rheumatology, Birmingham VA, Birmingham, AL, 2Department of Medicine, University of Alabama, Tuscaloosa, AL, 3Mayo Clinic College of Medicine, Rochester, MN, 4Mayo Clinic, Rochester, MN, 5Orthopedics, Mayo Clinic college of medicine, Rochester, MN

    Background/Purpose: The KSS questionnaire has previously been shown to have face, content and construct validity and test-retest reliability. Our objective was to assess the Responsiveness and Predictive…
  • Abstract Number: 2135 • 2013 ACR/ARHP Annual Meeting

    Musculoskeletal Pain Explains Differences In Function At Time Of Surgery In Black TKR and THR Patients

    Anthony Porter1, Wenjun Li2, Leslie R. Harrold1, Milagros Rosal3, Philip Noble4, David Ayers2, Patricia D. Franklin2 and Jeroan Allison5, 1University of Massachusetts Medical School, Worcester, MA, 2Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 3Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, MA, 4Baylor College of Medicine, Houston, TX, 5Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA

    Background/Purpose: The existence of racial disparities in total knee (TKR) and total hip (THR) replacement outcomes is well established but not well understood.  The burden…
  • Abstract Number: 2136 • 2013 ACR/ARHP Annual Meeting

    Does Functional Gain and Pain Relief After TKR and THR Differ By Patient Obese Status?

    Wenjun Li1, Leslie R. Harrold2, Jeroan Allison3, Courtland Lewis4, Thomas Bowen5, Patricia D. Franklin1 and David Ayers1, 1Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 2University of Massachusetts Medical School, Worcester, MA, 3Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, 4Hartford Hospital, Hartford, CT, 5Geisinger, Danville, PA

    Background/Purpose: Obesity is an important predictor of functional status and pain after total knee (TKR) and total hip (THR) replacement. However, variations in pre-post TKR…
  • Abstract Number: 2137 • 2013 ACR/ARHP Annual Meeting

    Important Predictors Of Patient-Reported Outcomes After TKR and THR Are Not Included In Risk Models Based On Administrative Data

    Patricia D. Franklin1, Leslie R. Harrold2, Wenjun Li1, Jeroan Allison3, David Ayers1 and Courtland Lewis4, 1Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 2University of Massachusetts Medical School, Worcester, MA, 3Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, 4Hartford Hospital, Hartford, CT

    Background/Purpose: Because total knee (TKR) and total hip (THR) replacement surgery is performed to relieve pain and improve physical function in patients with advanced arthritis,…
  • Abstract Number: 2139 • 2013 ACR/ARHP Annual Meeting

    Do Hyaluronic Acid Injections Delay Total Knee Replacement Surgery?

    Thomas Abbott1, Roy D. Altman2, Robert Dimeff3, Michael Fredericson4, Vijay Vad5, Peter Vitanzo Jr.6, Sashi Yadalam1, Ronald Levine1, Brad Bisson7 and Samir Bhattacharyya7, 1Johnson & Johnson, New Brunswick, NJ, 2David Geffen School of Medicine, UCLA, Los Angeles, CA, 3UT Southwestern Medical Center, Dallas, TX, 4Stanford University School of Medicine, Menlo Park, CA, 5Weill Cornell Medical College, NY, NY, 6Rothman Institute, Philadelphia, PA, 7DePuy Synthes Mitek Sports Medicine, Raynham, MA

    Background/Purpose:  More than 27 million adults in the US have knee osteoarthritis (OA), a painful and life-altering disease. Various non-pharmacologic and pharmacologic agents are recommended…
  • Abstract Number: 2140 • 2013 ACR/ARHP Annual Meeting

    Effects Of Intra-Articular Hyaluronic Acid Injections On Gait Pattern In Patients With Knee Osteoarthritis

    Bilal Uysal1, Aysegul Ketenci2, Sina Esmaeilzadeh2 and Dilsad Sindel2, 1Physical Medicine And Rehabilitation, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Physical Medicine and Rehabilitation, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

    Background/Purpose: The aim of this study was to determine the effects of intra-articular hyaluronic acid (HA) injections on gait pattern of both injected and un-injected…
  • Abstract Number: 2141 • 2013 ACR/ARHP Annual Meeting

    Interphalangeal Intra-Articular Injection With Triamcinolone Hexacetonide: Assessment Of effectiveness  In Hand Osteoarthritis

    Natalia de Oliva Spolidoro1, Jamil Natour2, Rita N.V. Furtado3, Flavia S. Machado3 and Hilda A. Oliveira4, 1Rheumatology Division, Universidade Federal de São Paulo - Unifesp, São Paulo, Brazil, 2Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 3Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, 4Rheumatology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil

    Background/Purpose: Despite being a very prevalent joint condition, there is a lack of studies on the effectiveness of the intra-articular injection (IAI) of corticosteroids in…
  • « Previous Page
  • 1
  • …
  • 2288
  • 2289
  • 2290
  • 2291
  • 2292
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology